221 related articles for article (PubMed ID: 12950445)
1. A comparison of amyloid fibrillogenesis using the novel fluorescent compound K114.
Crystal AS; Giasson BI; Crowe A; Kung MP; Zhuang ZP; Trojanowski JQ; Lee VM
J Neurochem; 2003 Sep; 86(6):1359-68. PubMed ID: 12950445
[TBL] [Abstract][Full Text] [Related]
2. The fluorescent Congo red derivative, (trans, trans)-1-bromo-2,5-bis-(3-hydroxycarbonyl-4-hydroxy)styrylbenzene (BSB), labels diverse beta-pleated sheet structures in postmortem human neurodegenerative disease brains.
Schmidt ML; Schuck T; Sheridan S; Kung MP; Kung H; Zhuang ZP; Bergeron C; Lamarche JS; Skovronsky D; Giasson BI; Lee VM; Trojanowski JQ
Am J Pathol; 2001 Sep; 159(3):937-43. PubMed ID: 11549586
[TBL] [Abstract][Full Text] [Related]
3. A novel tool for detecting amyloid deposits in systemic amyloidosis in vitro and in vivo.
Ando Y; Haraoka K; Terazaki H; Tanoue Y; Ishikawa K; Katsuragi S; Nakamura M; Sun X; Nakagawa K; Sasamoto K; Takesako K; Ishizaki T; Sasaki Y; Doh-ura K
Lab Invest; 2003 Dec; 83(12):1751-9. PubMed ID: 14691293
[TBL] [Abstract][Full Text] [Related]
4. Detection of filamentous tau inclusions by the fluorescent Congo red derivative FSB [(trans,trans)-1-fluoro-2,5-bis(3-hydroxycarbonyl-4-hydroxy)styrylbenzene].
Velasco A; Fraser G; Delobel P; Ghetti B; Lavenir I; Goedert M
FEBS Lett; 2008 Mar; 582(6):901-6. PubMed ID: 18291106
[TBL] [Abstract][Full Text] [Related]
5. Fluoro-substituted and 13C-labeled styrylbenzene derivatives for detecting brain amyloid plaques.
Sato K; Higuchi M; Iwata N; Saido TC; Sasamoto K
Eur J Med Chem; 2004 Jul; 39(7):573-8. PubMed ID: 15236837
[TBL] [Abstract][Full Text] [Related]
6. K114 (trans, trans)-bromo-2,5-bis(4-hydroxystyryl)benzene is an efficient detector of cationic amyloid fibrils.
Selmani V; Robbins KJ; Ivancic VA; Lazo ND
Protein Sci; 2015 Mar; 24(3):420-5. PubMed ID: 25524064
[TBL] [Abstract][Full Text] [Related]
7. Mechanism of A beta(1-40) fibril-induced fluorescence of (trans,trans)-1-bromo-2,5-bis(4-hydroxystyryl)benzene (K114).
LeVine H
Biochemistry; 2005 Dec; 44(48):15937-43. PubMed ID: 16313197
[TBL] [Abstract][Full Text] [Related]
8. Fibrils formed in vitro from alpha-synuclein and two mutant forms linked to Parkinson's disease are typical amyloid.
Conway KA; Harper JD; Lansbury PT
Biochemistry; 2000 Mar; 39(10):2552-63. PubMed ID: 10704204
[TBL] [Abstract][Full Text] [Related]
9. More than just two peas in a pod: common amyloidogenic properties of tau and alpha-synuclein in neurodegenerative diseases.
Lee VM; Giasson BI; Trojanowski JQ
Trends Neurosci; 2004 Mar; 27(3):129-34. PubMed ID: 15036877
[TBL] [Abstract][Full Text] [Related]
10. From genetics to pathology: tau and alpha-synuclein assemblies in neurodegenerative diseases.
Goedert M; Spillantini MG; Serpell LC; Berriman J; Smith MJ; Jakes R; Crowther RA
Philos Trans R Soc Lond B Biol Sci; 2001 Feb; 356(1406):213-27. PubMed ID: 11260802
[TBL] [Abstract][Full Text] [Related]
11. Isomerization of (Z,Z) to (E,E)1-bromo-2,5-bis-(3-hydroxycarbonyl-4-hydroxy)styrylbenzene in strong base: probes for amyloid plaques in the brain.
Lee CW; Zhuang ZP; Kung MP; Plössl K; Skovronsky D; Gur T; Hou C; Trojanowski JQ; Lee VM; Kung HF
J Med Chem; 2001 Jul; 44(14):2270-5. PubMed ID: 11428920
[TBL] [Abstract][Full Text] [Related]
12. [Novel tool for diagnosis of amyloidosis].
Obayashi K; Ando Y
Rinsho Byori; 2008 Nov; 56(11):986-93. PubMed ID: 19086454
[TBL] [Abstract][Full Text] [Related]
13. The significance of tau and alpha-synuclein inclusions in neurodegenerative diseases.
Goedert M
Curr Opin Genet Dev; 2001 Jun; 11(3):343-51. PubMed ID: 11377973
[TBL] [Abstract][Full Text] [Related]
14. Initiation and synergistic fibrillization of tau and alpha-synuclein.
Giasson BI; Forman MS; Higuchi M; Golbe LI; Graves CL; Kotzbauer PT; Trojanowski JQ; Lee VM
Science; 2003 Apr; 300(5619):636-40. PubMed ID: 12714745
[TBL] [Abstract][Full Text] [Related]
15. Investigation of α-Synuclein Amyloid Fibrils Using the Fluorescent Probe Thioflavin T.
Sulatskaya AI; Rodina NP; Sulatsky MI; Povarova OI; Antifeeva IA; Kuznetsova IM; Turoverov KK
Int J Mol Sci; 2018 Aug; 19(9):. PubMed ID: 30142878
[TBL] [Abstract][Full Text] [Related]
16. Filamentous nerve cell inclusions in neurodegenerative diseases: tauopathies and alpha-synucleinopathies.
Goedert M
Philos Trans R Soc Lond B Biol Sci; 1999 Jun; 354(1386):1101-18. PubMed ID: 10434313
[TBL] [Abstract][Full Text] [Related]
17. Neuropathology of synuclein aggregates.
Duda JE; Lee VM; Trojanowski JQ
J Neurosci Res; 2000 Jul; 61(2):121-7. PubMed ID: 10878583
[TBL] [Abstract][Full Text] [Related]
18. Novel method for quantitative determination of amyloid fibrils of alpha-synuclein and amyloid beta/A4 protein by using resveratrol.
Ahn JS; Lee JH; Kim JH; Paik SR
Anal Biochem; 2007 Aug; 367(2):259-65. PubMed ID: 17597573
[TBL] [Abstract][Full Text] [Related]
19. Review: formation and properties of amyloid-like fibrils derived from alpha-synuclein and related proteins.
El-Agnaf OM; Irvine GB
J Struct Biol; 2000 Jun; 130(2-3):300-9. PubMed ID: 10940234
[TBL] [Abstract][Full Text] [Related]
20. Red emissive fluorescent carbon dots based on ternary carbon source for imaging α-synuclein fibrils.
Zhang J; Luo WC; Zhang Y; Li X; Jiang M; Huang K; Yu X; Xu L
J Colloid Interface Sci; 2024 Sep; 670():576-584. PubMed ID: 38776692
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
